… therapy significantly reduced LDL cholesterol and triglyceride levels; ezetimibe … with ezetimibe,
niacin had greater efficacy regarding the change in mean carotid intima–media thickness …

… the combination of statins and extended-release niacin slowed the progression of carotid
atherosclerosis in a superior manner to combination with ezetimibe and statins monotherapy […

… randomized to receive ezetimibe at 10 mg/d or extended-release niacin with a … carotid
intimal-media thickness following 14 months of therapy. The images of the carotid intimal thickness …

… with combination therapy with atorvastatin, extended release niacin, and colesevelam for 3
… of extended-release niacin to a background of simvastatin 40 to 80 mg daily plus ezetimibe …

… with extended-release niacin (ERN) or ezetimibe; both … ezetimibe did not show any change
[27, 28]. Paradoxically there was an increase in cIMT with the fall in LDL-C in the ezetimibe …

… combination ezetimibe/simvastatin (E/S) plus extended-release niacin … niacin (to 2 g) or
E/S (10/20 mg) for 64 weeks, or niacin (to 2 g) for 24 weeks and then E/S (10/20 mg) plus niacin (…

… ezetimibe treatment group, but not the niacin treatment group, were significantly inversely
correlated to mean cIMT. This correlation implies that ezetimibe-… receptor B1 by ezetimibe, thus …

… , carotid intima-media thickness did not change significantly from baseline among patients
in the statin/niacin … treated with statin/niacin ER, absolute regression of carotid intima-media …

… release niacin is under development [109]. Nolting and coll… intima-media thickness of the
walls of the carotid and femoral arteries. In patients with HFH, combined therapy with ezetimibe …

… changes in carotid intima-media thickness (CIMT) and carotid plaque morphology in … plus
niacin and ezetimibe. The dates of the annual CIMT study served as the primary analysis time …